Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GBA1 | P04062 | 8/20 | 0.34 |
| ▸ | SI | P14410 | 1/20 | 0.32 |
| ▸ | PYGL | P06737 | 1/20 | 0.32 |
| ▸ | GBA2 | Q9HCG7 | 1/20 | 0.32 |
| ▸ | FUCA1 | P04066 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | GLB1 | P16278 | 1/20 | 0.32 |
| ▸ | OGA | O60502 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14534024 | 1.00 | GBA1 (0.34) | GBA1SIPYGLGBA2FUCA1 | |
| SCHEMBL10293829 | 1.00 | GBA1 (0.34) | GBA1SIPYGLGBA2FUCA1 | |
| SCHEMBL25100472 | 0.85 | GANAB (0.30) | — | |
| SCHEMBL12870808 | 0.85 | GANAB (0.30) | — | |
| SCHEMBL17691133 | 0.83 | SI (0.43) | GBA1SIPYGLGBA2FUCA1 | |
| SCHEMBL14455193 | 0.82 | CA1 (0.39) | GBA1SIPYGLGBA2GAA | |
| SCHEMBL6909346 | 0.82 | CA1 (0.39) | GBA1SIPYGLGBA2GAA | |
| SCHEMBL3480518 | 0.82 | INPP5A (0.35) | GBA1SIPYGLGBA2FUCA1 | |
| SCHEMBL3480023 | 0.82 | INPP5A (0.35) | GBA1SIPYGLGBA2FUCA1 | |
| SCHEMBL13167672 | 0.80 | INPP5A (0.31) | SIFUCA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160046671-A1 | STABILIZED SOS1 PEPTIDES | DANA-FARBER CANCER INSTITUTE, INC. | 2016-02-18 | — | — | US | disclosed |
| US-20040091515-A1 | Noxious-insect repellent | KANEBO, LTD. | 2004-05-13 | — | — | US | disclosed |
| US-6686396-B2 | NO OFFENSIVE ODOR AND EXHIBIT EXCELLENT NOXIOUS-INSECT REPELLING EFFECT AND DURABILITY | KANEBO, LTD. (JP) | 2004-02-03 | — | — | US | disclosed |
| US-6677384-B1 | CARBOCYCLIC ALCOHOLS SUCH AS 2-HYDROXYMETHYL-3,3,5-TRIMETHYL-CYCLOHEXANOL USED AS ODORLESS, DURABLE LOTIONS TO PREVENT DISEASES | KANEBO, LTD. (JP) | 2004-01-13 | — | — | US | disclosed |
| US-20020143070-A1 | Noxious-insect repellent | KANEBO, LTD. | 2002-10-03 | — | — | US | disclosed |
| US-6372804-B1 | HYDROXYALKYLCYCLOALKANOLS REPELLENTS | KANEBO, LTD. (JP) | 2002-04-16 | — | — | US | disclosed |
| US-6130255-A | EXPOSING NOXIOUS INSECTS TO REPELLENT COMPRISING 2-(1-HYDROXYALKYL)-CYCLOALKANOLS HAVING NO OFFENSIVE ODOR | KAO CORPORATION (JP) | 2000-10-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020143070-A1 | Noxious-insect repellent | OPRM1, OPRD1, L3MBTL1 | GBA1 4407/4885SI 4259/4885PYGL 4859/4885 |
| US-20040091515-A1 | Noxious-insect repellent | OPRM1, OPRD1, OPRK1 | GBA1 4620/4885SI 3742/4885PYGL 4817/4885 |
| US-20160046671-A1 | STABILIZED SOS1 PEPTIDES | RASGRP1, KRAS, RASGRP3 | GBA1 621/4885SI 2989/4885PYGL 1316/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.